Denmark's Novo acquires Xellia Pharmaceuticals in $700-million deal

09:06 AM | May 22, 2013 | Francinia Protti-Alvarez

Novo A/S (Hellerup, Denmark), parent of pharmaceutical firm Novo Nordisk (Bagsvaerd, Denmark), has acquired Xellia Pharmaceuticals (Oslo) from private equity firm 3i (London) for an enterprise value...